Shanghai Pharmaceuticals (02607) Releases Extraordinary General Meeting Notice

Bulletin Express11-18

Shanghai Pharmaceuticals (02607) has announced that its Extraordinary General Meeting will be held on December 9, 2025, at 14:00. The venue is the Meeting Room on the second floor of Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai, the People’s Republic of China.

Holders of H shares who wish to attend the meeting (in person or by proxy) should complete the reply slip, providing the shareholder’s name, address, and the number of H shares registered in their name. Completed reply slips must be delivered to Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, on or before November 28, 2025, either in person or by mail.

For shareholders intending to vote at the meeting, it is required that all transfer documents, along with the relevant share certificates, are lodged with the same registrar no later than 16:30 on December 3, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment